High-resolution conformation and backbone dynamics of a soluble aggregate of apomyoglobin119

Biophysical Journal

Volumn 100, Issue 3, 2011, Pages 747-755

  Rajagopalan, Senapathy ^a,b,c   Kurt, Nesxe ^a   Cavagnero, Silvia ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHYSETERIDAE;

EID: 79551668313     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2010.12.3722     Document Type: Article

References (72)

1. Jellinger, K. A. 2010. Basic mechanisms of neurodegeneration: a critical update. J. Cell. Mol. Med. 14:457-487.
2. Uversky, V. N. 2010. Mysterious oligomerization of the amyloidogenic proteins. FEBS J. 277:2940-2953.
3. Ramirez-Alvarado, M. 2008. Principles of protein misfolding. In Progress in Molecular Biology and Translational Science. Molecular Biology of Protein Folding, Part B. 84:115-160.
4. Bucciantini, M., E. Giannoni, M. Stefani. 2002. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 416:507-511.
5. Dember, L. M. 2006. Amyloidosis-associated kidney disease. J. Am. Soc. Nephrol. 17:3458-3471.
6. Sakono, M., and T. Zako. 2010. Amyloid oligomers: formation and toxicity of Ab oligomers. FEBS J. 277:1348-1358.
7. Kitamura, A., and H. Kubota. 2010. Amyloid oligomers: dynamics and toxicity in the cytosol and nucleus. FEBS J. 277:1369-1379.
8. Goto, Y., H. Yagi, T. Ban. 2008. Structure, formation and propagation of amyloid fibrils. Curr. Pharm. Des. 14:3205-3218.
9. Tycko, R. 2006. Molecular structure of amyloid fibrils: insights from solid-state NMR. Q. Rev. Biophys. 39:1-55.
10. Nelson, R., and D. Eisenberg. 2006. Recent atomic models of amyloid fibril structure. Curr. Opin. Struct. Biol. 16:260-265.
11. Irie, K., K. Murakami, T. Shirasawa. 2005. Structure of β-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease. J. Biosci. Bioeng. 99:437-447.
12. Roychaudhuri, R., M. Yang, D. B. Teplow. 2009. Amyloidβ-protein assembly and Alzheimer disease. J. Biol. Chem. 284:4749-4753.
13. Teplow, D. B., N. D. Lazo, H. E. Stanley. 2006. Elucidating amyloid β-protein folding and assembly: a multidisciplinary approach. Acc. Chem. Res. 39:635-645.
14. Lazo, N. D., M. A. Grant, D. B. Teplow. 2005. On the nucleation of amyloid β-protein monomer folding. Protein Sci. 14:1581-1596.
15. Lesné, S., M. T. Koh, K. H. Ashe. 2006. A specific amyloid β protein assembly in the brain impairs memory. Nature. 440:352-357.
16. Townsend, M., G. M. Shankar, D. J. Selkoe. 2006. Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572:477-492.
17. Li, S. M., S. Y. Hong, D. Selkoe. 2009. Soluble oligomers of amyloid β protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron. 62:788-801.
18. Walsh, D. M., and D. J. Selkoe. 2004. Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron. 44:181-193.
19. Lambert, M. P., A. K. Barlow, W. L. Klein. 1998. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA. 95:6448-6453.
20. Hsia, A. Y., E. Masliah, L. Mucke. 1999. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA. 96:3228-3233.
21. Roher, A. E., M. O. Chaney, M. R. Emmerling. 1996. Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271:20631-20635.
22. Fändrich, M., M. A. Fletcher, and C. M. Dobson. 2001. Amyloid fibrils from muscle myoglobin. Nature. 410:165-166.
23. Pallarès, I., J. Vendrell, S. Ventura. 2004. Amyloid fibril formation by a partially structured intermediate state of α-chymotrypsin. J. Mol. Biol. 342:321-331.
24. Frare, E., P. Polverino de Laureto, A. Fontana. 2004. A highly amyloidogenic region of hen lysozyme. J. Mol. Biol. 340:1153-1165.
25. Wiseman, R. L., E. T. Powers, and J. W. Kelly. 2005. Partitioning conformational intermediates between competing refolding and aggregation pathways: insights into transthyretin amyloid disease. Biochemistry. 44:16612-16623.
26. Chow, C., N. Kurt, S. Cavagnero. 2006. Structural characterization of apomyoglobin self-associated species in aqueous buffer and urea solution. Biophys. J. 90:298-309.
27. Calamai, M., F. Chiti, and C. M. Dobson. 2005. Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys. J. 89:4201-4210.
28. Ahmad, B., J. Winkelmann, F. Chiti. 2010. Searching for conditions to form stable protein oligomers with amyloid-like characteristics: the unexplored basic pH. Biochim. Biophys. Acta. 1804:223-234.
29. Khare, S. D., and N. V. Dokholyan. 2007. Molecular mechanisms of polypeptide aggregation in human diseases. Curr. Protein Pept. Sci. 8:573-579.
30. Yu, L. P., R. Edalji, E. T. Olejniczak. 2009. Structural characterization of a soluble amyloid β-peptide oligomer. Biochemistry. 48:1870-1877.
31. Gellermann, G. P., H. Byrnes, S. Barghorn. 2008. Aβ-globulomers are formed independently of the fibril pathway. Neurobiol. Dis. 30:212-220.
32. Bocian, W., J. Sitkowski, L. Kozerski. 2008. Direct insight into insulin aggregation by 2D NMR complemented by PFGSE NMR. Proteins. 71:1057-1065.
33. Barghorn, S., V. Nimmrich, H. Hillen. 2005. Globular amyloid β-peptide oligomer-a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95:834-847.
34. Chugh, J., A. Chatterjee, R. V. Hosur. 2006. Structural characterization of the large soluble oligomers of the GTPase effector domain of dynamin. FEBS J. 273:388-397.
35. Chugh, J., S. Sharma, and R. V. Hosur. 2008. NMR insights into a megaDalton-size protein self-assembly. Protein Sci. 17:1319-1325.
36. Juneja, J., N. S. Bhavesh, R. V. Hosur. 2002. NMR identification and characterization of the flexible regions in the 160 kDa molten globule-like aggregate of barstar at low pH. Biochemistry. 41:9885-9899.
37. Chow, C. C., C. Chow, S. Cavagnero. 2003. Chain length dependence of apomyoglobin folding: structural evolution from misfolded sheets to native helices. Biochemistry. 42:7090-7099.
38. Reference deleted in proof.
39. Kurt, N., S. Rajagopalan, and S. Cavagnero. 2006. Effect of Hsp70 chaperone on the folding and misfolding of polypeptides modeling an elongating protein chain. J. Mol. Biol. 355:809-820.
40. Van Geet, A. L. 1970. Calibration of methanol nuclear magnetic resonance thermometer at low temperature. Anal. Chem. 42:679-680.
41. Delaglio, F., S. Grzesiek, A. Bax. 1995. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR. 6:277-293.
42. Johnson, B. A., and R. A. Blevins. 1994. NMRView-a computer program for the visualization and analysis of NMR data. J. Biomol. NMR. 4:603-614.
43. Mulder, F. A. A., C. Spronk, R. Boelens. 1996. Improved HSQC experiments for the observation of exchange broadened signals. J. Biomol. NMR. 8:223-228.
44. Pervushin, K., R. Riek, K. Wüthrich. 1997. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. USA. 94:12366-12371.
45. Tzakos, A. G., C. R. R. Grace, R. Riek. 2006. NMR techniques for very large proteins and RNAs in solution. Annu. Rev. Biophys. Biomol. Struct. 35:319-342.
46. Wider, G., and K. Wüthrich. 1999. NMR spectroscopy of large molecules and multimolecular assemblies in solution. Curr. Opin. Struct. Biol. 9:594-601. (Pubitemid 29460586)
47. Wider, G. 2005. NMR techniques used with very large biological macromolecules in solution. In Methods in Enzymology. Nuclear Magnetic Resonance of Biological Macromolecules, Part C. 394:382-398.
48. Fernández, C., and G. Wider. 2003. TROSY in NMR studies of the structure and function of large biological macromolecules. Curr. Opin. Struct. Biol. 13:570-580.
49. 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects. J. Biomol. NMR. 5:67-81.
50. 15N NMR relaxation. Biochemistry. 33:5984-6003.
51. Mosteller, F., and J. W. Tukey. 1977. Data Analysis and Regression: a Second Course in Statistics. Addison-Wesley, Boston, MA.
52. Abragam, A. 1961. The Principles of Nuclear Magnetism. Clarendon Press, Oxford, UK, pp. 599.
53. 15N]glycine benzyl ester. J. Am. Chem. Soc. 110:2378-2383.
54. 15N relaxation data exclusively. J. Biomol. NMR. 6:153-162.
55. Peng, J. W., and G. Wagner. 1992. Mapping of spectral density functions using heteronuclear NMR relaxation measurements. J. Magn. Reson. 98:308-332.
56. Peng, J. W., and G. Wagner. 1994. Investigation of protein motions via relaxation measurements. Methods Enzymol. 239:563-596.
57. Kurt, N., and S. Cavagnero. 2005. The burial of solvent-accessible surface area is a predictor of polypeptide folding and misfolding as a function of chain elongation. J. Am. Chem. Soc. 127:15690-15691.
58. Cantor, C. R., and P. R. Schimmel. 1980. Biophysical Chemistry. Freeman, New York.
59. Wishart, D. S., and B. D. Sykes. 1994. Chemical shifts as a tool for structure determination. In Methods in Enzymology. Nuclear Magnetic Resonance, Part C. 239:363-392.
60. Spera, S., and A. Bax. 1991. Empirical correlation between protein backbone conformation and C-α and C-β C-13 nuclear-magnetic-resonance chemical-shifts. J. Am. Chem. Soc. 113:5490-5492.
61. Eliezer, D., and P. E. Wright. 1996. Is apomyoglobin a molten globule? Structural characterization by NMR. J. Mol. Biol. 263:531-538.
62. Kay, L. E., P. Keifer, and T. Saarinen. 1992. Pure absorption gradient enhanced heteronuclear single quantum correlation spectroscopy with improved sensitivity. J. Am. Chem. Soc. 114:10663-10665.
63. Lipari, G., and A. Szabo. 1982. Model-free approach to the interpretation of nuclear magnetic-resonance relaxation in macromolecules. 1. Theory and range of validity. J. Am. Chem. Soc. 104:4546-4559.
64. Clore, G. M., A. Szabo, A. M. Gronenborn. 1990. Deviations from the simple 2-parameter model-free approach to the interpretation of N-15 nuclear magnetic-relaxation of proteins. J. Am. Chem. Soc. 112:4989-4991.
65. Modig, K., and F. M. Poulsen. 2008. Model-independent interpretation of NMR relaxation data for unfolded proteins: the acid-denatured state of ACBP. J. Biomol. NMR. 42:163-177.
66. Buevich, A. V., and J. Baum. 1999. Dynamics of unfolded proteins: Incorporation of distributions of correlation times in the model free analysis of NMR relaxation data. J. Am. Chem. Soc. 121:8671-8672.
67. Lefevre, J. F., K. T. Dayie, G. Wagner. 1996. Internal mobility in the partially folded DNA binding and dimerization domains of GAL4: NMR analysis of the N-H spectral density functions. Biochemistry. 35:2674-2686.
68. Rüdiger, S., L. Germeroth, B. Bukau. 1997. Substrate specificity of the DnaK chaperone determined by screening cellulose-bound peptide libraries. EMBO J. 16:1501-1507.
69. Chen, Z., N. Kurt, S. Cavagnero. 2006. Secondary structure mapping of DnaK-bound protein fragments: chain helicity and local helix unwinding at the binding site. Biochemistry. 45:12325-12333.
70. Kuriyan, J., S. Wilz, G. A. Petsko. 1986. X-ray structure and refinement of carbon-monoxy (Fe II)-myoglobin at 1.5 Å resolution. J. Mol. Biol. 192:133-154.
71. Rose, G. D., A. R. Geselowitz, M. H. Zehfus. 1985. Hydrophobicity of amino acid residues in globular proteins. Science. 229:834-838.
72. Vega, C. A., N. Kurt, S. Cavagnero. 2006. Binding specificity of an α-helical protein sequence to a full-length Hsp70 chaperone and its minimal substrate-binding domain. Biochemistry. 45:13835-13846.